Fla. cancer center pays $12 million in fraud settlement

Mar 23, 2010

The U.S. Department of Justice announced yesterday that a large multispecialty physician group in Florida has agreed to pay $12 million to settle allegations that it submitted false reimbursement claims for radiation oncology treatments to federal healthcare agencies.

Click here to read the rest of the article.

Latest in Radiation Oncology/Therapy
Raysearch Astro 2019 (1)
RaySearch Laboratories posts interim report
August 8, 2025
Siemens Rsna 2021 400
Siemens Healthineers, Prisma Health expand partnership in cancer care
July 29, 2025
Law Books
N.C. legislators address imaging, radiation therapy licensing
July 24, 2025
Ray Search
RaySearch Laboratories inks cancer center deal with AKSM/Oncology
July 21, 2025
Related Stories
2009 03 25 14 14 33 939 Capitol Hill 70
Digital X-Ray
Medical groups tell Congress more radiation rules are needed
2009 11 12 17 39 08 655 2009 03 02 Radioactive Symbol
Nuclear Medicine
FDA launches initiative to rein in medical radiation
2009 03 25 14 14 33 939 Capitol Hill 70
Digital X-Ray
Congress sets hearing to review medical radiation
2009 01 15 16 03 49 510 Med Phys Web Logo 100
Radiation Oncology/Therapy
Radiation therapy markers may have role in drug delivery
More in Radiation Oncology/Therapy
RaySearch Laboratories posts interim report
By AuntMinnie.com staff writers
Net sales up at a slightly lower operating and after tax profit.
August 8, 2025
Raysearch Astro 2019 (1)
Siemens Healthineers, Prisma Health expand partnership in cancer care
By AuntMinnie.com staff writers
Siemens and Prisma Health are expanding their Value Partnership with greater access to advanced cancer care across Prisma’s network.
July 29, 2025
Siemens Rsna 2021 400
N.C. legislators address imaging, radiation therapy licensing
By AuntMinnie.com staff writers
North Carolina is one of only five states with no standards or licensing structure for medical imaging or radiation therapy.
July 24, 2025
Law Books
RaySearch Laboratories inks cancer center deal with AKSM/Oncology
By AuntMinnie.com staff writers
RaySearch's RayCare oncology information system and RayStation treatment planning system will be used at a new center in California.
July 21, 2025
Ray Search
RaySearch partners with Radiology Oncology Systems
By AuntMinnie.com staff writers
RaySearch plans to integrate advanced radiation therapy software into refurbished linear accelerators.
July 18, 2025
Raysearch Astro Cr 2019
Radiology drives July FDA AI-enabled medical device update
By Liz Carey
The U.S. FDA has just publicly listed 211 AI-enabled medical devices that have received regulatory clearances
July 14, 2025
Fda Sign Dc 400 (1)
Sirtex Medical gains additional U.S. FDA clearance for SIR-Spheres Y-90
The microspheres are for the treatment of unresectable hepatocellular carcinoma (HCC).
July 7, 2025
Liver Cancer
Alpha Fusion and Curadh partner
By AuntMinnie.com staff writers
Alpha Fusion and Curadh MTR will establish a joint venture to develop astatine-211-based radiopharmaceuticals.
July 2, 2025
Business Handshake Man
GT Medical Technologies receives excellence program designation
By AuntMinnie.com staff writers
The program recognizes leaders in patient care dedicated to advancing brain tumor treatment.
June 30, 2025
Trophy Award
RaySearch releases v2025 RayCare oncology information system
By AuntMinnie.com staff writers
Features in the upgrade include the company's Health Level Seven (HL7) inbound scheduling support.
June 27, 2025
Raysearch Astro Cr 2019
SNMMI: Novel adaptive radiotherapy system improves tumor response monitoring
By Liz Carey
Initial results from UT Southwestern Medical Center may advance adaptive radiation therapy.
June 24, 2025
Tumor changes observed at each fraction in the adaptive system.
SNMMI: SPECT/CT valuable after Lu-177 therapy
By Will Morton
Post-therapy SPECT/CT imaging can optimize treatment outcomes and protected patients undergoing radiopharmaceutical therapy.
June 21, 2025
Top image displays a patient assessed for acute renal failure following third Lutathera administration where 3D dosimetry showed an average-per-administration kidney absorbed dose of 5 Gray, with total course of therapy being well under toxicity limits. Bottom image displays a patient’s absorbed dose to the colon after his first dose of Pluvicto where 3D dosimetry was used to confirm transient bowel obstruction leading to treatment management.
Page 1 of 464
Next Page